Sridhar Kosaraju
Director/Board Member at 10X GENOMICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Presently, Sridhar Kosaraju is Chief Executive Officer & Director at Inscripta, Inc. He is also on the board of 10X Genomics, Inc. In the past Mr. Kosaraju occupied the position of President of Penumbra, Inc. and Managing Director-Equity Capital Markets at JPMorgan Securities LLC. Sridhar Kosaraju received an undergraduate degree from Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
10X GENOMICS INC CLASS A
0.03% | 2023-06-13 | 35,443 ( 0.03% ) | 1 M $ | 2024-03-30 |
NEVRO CORP.
0.05% | 2024-03-30 | 18,486 ( 0.05% ) | 266 938 $ | 2024-03-30 |
Sridhar Kosaraju active positions
| Companies | Position | Start |
|---|---|---|
| 10X GENOMICS, INC. | Director/Board Member | 2019-02-28 |
| NEVRO CORP. | Director/Board Member | 2021-08-30 |
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Chief Executive Officer | 2020-10-26 |
| Testing For America | Director/Board Member | - |
Former positions of Sridhar Kosaraju
| Companies | Position | End |
|---|---|---|
| PENUMBRA, INC. | Director of Finance/CFO | 2019-10-31 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 2015-04-30 |
Training of Sridhar Kosaraju
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PENUMBRA, INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| NEVRO CORP. | Health Technology |
| Private companies | 3 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
| Testing For America |
- Stock Market
- Insiders
- Sridhar Kosaraju
